Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
FC Tenover, DP Nicolau, CM Gill - Emerging microbes & infections, 2022 - Taylor & Francis
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa - an emerging challenge.
FC Tenover, DP Nicolau, CM Gill - 2022 - cabidigitallibrary.org
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …
[HTML][HTML] Carbapenemase-producing Pseudomonas aeruginosa–an emerging challenge
FC Tenover, DP Nicolau, CM Gill - Emerging Microbes & Infections, 2022 - ncbi.nlm.nih.gov
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge.
FC Tenover, DP Nicolau, CM Gill - Emerging Microbes & Infections, 2022 - europepmc.org
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
[引用][C] Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
FC Tenover, DP Nicolau, CM Gill - Emerging Microbes & Infections, 2022 - cir.nii.ac.jp
Carbapenemase-producing <i>Pseudomonas aeruginosa</i> –an emerging challenge | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Carbapenemase-Producing Pseudomonas aeruginosa – an Emerging Challenge
FC Tenover, DP Nicolau… - Emerging Microbes & …, 2022 - ecommons.udayton.edu
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa–an emerging challenge
FC Tenover, DP Nicolau… - Emerging Microbes and …, 2022 - search.proquest.com
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa–an emerging challenge
FC Tenover, DP Nicolau, CM Gill - 2022 - agris.fao.org
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa-an emerging challenge
FC Tenover, DP Nicolau… - Emerging microbes & …, 2022 - pubmed.ncbi.nlm.nih.gov
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …
Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge.
FC Tenover, DP Nicolau, CM Gill - Emerging Microbes & Infections, 2022 - europepmc.org
Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …
pathogen worldwide. In the United States, 10-30% of P. aeruginosa isolates are …